Karen Akinsanya

Director/Board Member presso NAUTILUS BIOTECHNOLOGY, INC.

Patrimonio netto: - $ in data 31/03/2024

56 anni

100 relazioni

Consumer Services

Health Technology

Technology Services

Profilo

Karen Akinsanya is the founder of Envision Science Group LLC, which was founded in 2007.
She holds the title of President at Envision Science Group LLC.
Dr. Akinsanya's current jobs include being an Independent Director at Nautilus Biotechnology, Inc. since 2022, a Trustee at The Rockefeller University, and the President-Research & Development Therapeutics at Schrödinger, Inc. since 2018.
Dr. Akinsanya's former job was as a Vice President at Merck & Co., Inc. from 2013 to 2017.
She received her undergraduate degree from Queen Mary University of London and her doctorate from Royal Postgraduate Medical School.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
SCHRODINGER, INC. -.--%	01/04/2024	0 ( -.--% )	- $	31/03/2024

Posizioni attive di Karen Akinsanya

Società	Posizione	Inizio
SCHRÖDINGER, INC.	Corporate Officer/Principal	01/04/2018
NAUTILUS BIOTECHNOLOGY, INC.	Director/Board Member	30/03/2022
Envision Science Group LLC	Founder	01/01/2007
The Rockefeller University	Director/Board Member	-